Singulair-induced anaphylaxis?
Gerard
Adriel
A
State University of New York at Buffalo School of Medicine, Buffalo, NY, USA. adriel.gerard@gmail.com
Harkisoon
Shantie
S
D000085:Acetates / Q000008:administration & dosage / Q000009:adverse effects*; D000707:Anaphylaxis / Q000139:chemically induced* / Q000276:immunology; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001249:Asthma / Q000150:complications; D002675:Child, Preschool; D003233:Conjunctivitis, Allergic / Q000150:complications* / Q000188:drug therapy; D003521:Cyclopropanes; D003876:Dermatitis, Atopic / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007223:Infant; D020024:Leukotriene Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D011379:Prognosis; D011804:Quinolines / Q000008:administration & dosage / Q000009:adverse effects*; D012130:Respiratory Hypersensitivity / Q000150:complications* / Q000188:drug therapy; D013440:Sulfides
D000085:Acetates; D018927:Anti-Asthmatic Agents; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast